<scp><i>Drosophila melanogaster</i></scp>models of<scp>MPS IIIC</scp>(<scp><i>Hgsnat</i></scp>‐deficiency) highlight the role of glia in disease presentation
Laura J. Hewson(The University of Adelaide), Louise V. O’Keefe(South Australian Health and Medical Research Institute), Kim M. Hemsley(South Australian Health and Medical Research Institute), Paul J. Trim(South Australian Health and Medical Research Institute), Anthony O. Fedele(Flinders Medical Centre), Marten F. Snel(South Australian Health and Medical Research Institute), Dani L. Webber(The University of Adelaide), John J. Hopwood(Women's and Children's Hospital), Amanda Choo(The University of Adelaide)
Cited by 3
Related Papers
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
|Molecular Genetics and Metabolism|2008|216
Mutations disrupting neuritogenesis genes confer risk for cerebral palsy
|Nature Genetics|2020|174
Replacing acid α-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers
|Molecular Therapy|2004|138
Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling
|Bioscience Reports|2020|114